Healthcare2 hours ago
Mankind Pharma Limited to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-generation CAR-T Therapies
Mankind Pharma Limited (NSE: MANKIND) announced its plan to acquire a majority stake in Armed Cell Therapeutics, marking a strategic move into next-generatio.